ArticleAME case reports2026
Fulminant neuropsychiatric lupus leading to brain death: a case report.
Article in AME case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neuropsychiatric systemic lupus erythematosus (NPSLE) represents a severe and heterogeneous manifestation of systemic lupus erythematosus (SLE), occasionally progressing to catastrophic outcomes. Although rare, fulminant forms with rapid neurological decline and brain death are exceptionally uncommon. Case Description: We report a 21-year-old woman with an 8-year history of SLE (articular, cutaneous, renal, and hematologic involvement) and hypothyroidism, who presented with acute neuropsychiatric symptoms and rapidly deteriorated to coma and brain death in less than 72 hours. Initial computed tomography (CT) was unremarkable. Laboratory results showed leukocytosis, negative anti-double-stranded DNA (dsDNA) antibodies, and normal complement (C3 and C4). Cerebrospinal fluid (CSF) revealed mild pleocytosis without infection. Despite intravenous methylprednisolone and multiple anticonvulsants, she developed refractory status epilepticus. Cranial CT angiography demonstrated severe cerebral and cerebellar edema, absent posterior circulation, and partial anterior circulation opacification; no definite hemorrhage was observed. Electroencephalogram (EEG) showed an isoelectric tracing after 24 hours off sedation, and brain death was confirmed in June 2025. Conclusions: The clinical course was consistent with fulminant cerebral involvement, possibly related to lupus vasculitis, though histologic confirmation was not possible. This case highlights that NPSLE may progress with extreme rapidity, underlining the importance of early suspicion, aggressive immunosuppression, and advanced imaging techniques, such as vessel-wall magnetic resonance imaging (MRI), which may improve timely diagnosis and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.